Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.

Abstract: A computing system or application that enables generation and use of code block elements. A code block element refers to a graphic element that is rendered on a canvas to include content in the form of program code.

Abstract: The present invention is directed to compositions, baths, and methods for composite plating where the composition and subsequent plating include polytetrafluoroethylene (PTFE), and more particularly, to compositions, baths, and methods of composite plating with PTFE included in a metal or alloy matrix where the materials used in the process, including materials in the composition, include no or essentially no PFAS (perfluoroalkyl substances) including PFOS (perfluorooctane sulfonate), GenX, PFOA (perfluorooctanoic acid), and/or fluorinated surfactants.

Abstract: Compositions for electroless plating baths and their use are disclosed, and more particularly different solutions each usable to both makeup an original bath and to replenishment of the original bath.

Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.

Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.

Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.

Abstract: The present technology relates to depot assemblies for the controlled, sustained release of a therapeutic agent. The assembly can include a depot having a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days. The assembly further includes a fixation portion coupled to the depot and configured to facilitate attachment of the depot assembly to tissue at or adjacent to the treatment site.

Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.

Abstract: The present technology relates to depot assemblies for the controlled, sustained release of a therapeutic agent. The assembly can include a depot having a therapeutic region comprising a therapeutic agent, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.

Abstract: The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.

Abstract: Described herein are improved configurations for an apparatus that may include a plurality of resonators electrically interconnected and arranged in an array to form a composite resonator for wireless power transfer, each one of the plurality of resonators may include a block of a magnetic material having a conductor wire wrapped around a cross section thereof to form at least one loop enclosing an area substantially equal to the cross section, wherein the plurality of resonators are may be oriented so that a dipole moment of each one of the plurality of resonators is aligned with a dipole moment of each other one of the plurality of resonators.

Abstract: In an example implementation, a method includes outputting, for display at a display device, a first content item and a first group of content indicators being of a first quantity. The method also includes outputting, for display, a second group of content indicators being of a second quantity, such that the first and second groups are visually separated by at least one graphical element. The method includes, responsive to receiving an indication of a request to display a second content item, outputting, for display, an updated first group of content indicators of a third quantity that is one fewer than the first quantity and outputting, for display, an updated second group of content indicators of a fourth quantity that is one more than the second quantity. The method also includes outputting, for display at the display device, the second content item.

Abstract: The disclosed technology includes using horizontal components and vertical components of a velocity vector associated with movement of an input gesture to determine a user's intended, dominant direction of movement and corresponding control function at various points during the input gesture. Thresholds may be dynamically adjusted to prevent a user from unintentionally changing control functions during the input gesture. By adjusting the sensitivity associated with changes in a direction of movement of a continuous input gesture, it can be made effectively more difficult for the user to unintentionally cause a change in control functions. In example implementations, one or more thresholds associated with changing a control function may be increased or decreased during a continuous input gesture. For example, the thresholds may be increased or decreased in proportion to an increase or decrease in a velocity vector component.

Abstract: An apparatus may include one or more memories and one or more processors. The one or more processors may be configured to execute instructions to facilitate providing a first window for display while hiding from display one or more additional windows. The instructions may facilitate receiving a switching input. The instructions may facilitate, in response to the switching input, providing a plurality of windows for display. The providing a plurality of windows may include changing a display view from the first window to the plurality of windows. The instructions may facilitate selecting one of the plurality of windows. The selecting one of the plurality of windows may include changing the display view from the plurality of windows to the selected one of the plurality of windows while hiding from display one or more other windows. Methods for displaying windows and machine-readable storage medium are also disclosed.

Abstract: An apparatus may include one or more memories and one or more processors. The one or more processors may be configured to execute instructions to facilitate providing a first window for display while hiding from display one or more additional windows. The instructions may facilitate receiving a switching input. The instructions may facilitate, in response to the switching input, providing a plurality of windows for display. The providing a plurality of windows may include changing a display view from the first window to the plurality of windows. The instructions may facilitate selecting one of the plurality of windows. The selecting one of the plurality of windows may include changing the display view from the plurality of windows to the selected one of the plurality of windows while hiding from display one or more other windows. Methods for displaying windows and machine-readable storage medium are also disclosed.

Abstract: In particular, the present invention is directed processes and product related to blackened coatings, blackened electroless nickel coatings, blackened electroless nickel coatings including particulate matter, coatings with cover coats, coatings with voids, and the methods of application and products with such coatings.

Abstract: An apparatus may include one or more memories and one or more processors. The one or more processors may be configured to execute instructions to facilitate providing a first application window for display. The instruction may facilitate receiving a switching input. The instructions may facilitate, in response to the switching input, providing a plurality of application windows for concurrent display. The providing a plurality of application windows may include changing a display view from the first application window to the plurality of application windows. The plurality of application windows include the first application window and one or more additional application windows. The instructions may facilitate touching and sliding, off the display view, one of the plurality of application windows. The sliding may cause permanently removing the one of the plurality of application windows from application windows available for display.

Abstract: Methods and systems for processing and displaying content are disclosed. An example method of operation may include initializing two or more windows on a mobile device, and displaying a first window of the two or more windows on the mobile device. The method may also include receiving an on-screen switcher indication causing a display view change from the first window being displayed to a combination of the first window and at least one more additional windows being displayed. The method may also include determining a space amount for each of the two or more windows, adjusting a size of each of the two or more windows based on the space amount. The method may further include displaying a frame around each of the two or more windows with the respective adjusted size, and displaying each frame overlaid on top of one another.

Abstract: An apparatus may include one or more memories and one or more processors. The one or more processors may be configured to execute instructions to facilitate providing a first application window for display. The instruction may facilitate receiving a switching input. The instructions may facilitate, in response to the switching input, providing a plurality of application windows for concurrent display. The providing a plurality of application windows may include changing a display view from the first application window to the plurality of application windows. The plurality of application windows include the first application window and one or more additional application windows. The instructions may facilitate touching and sliding, off the display view, one of the plurality of application windows. The sliding may cause permanently removing the one of the plurality of application windows from application windows available for display.